Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5185214
Max Phase: Preclinical
Molecular Formula: C53H69N5Na2O20S2
Molecular Weight: 1162.30
Associated Items:
ID: ALA5185214
Max Phase: Preclinical
Molecular Formula: C53H69N5Na2O20S2
Molecular Weight: 1162.30
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@@](OCCCSCCNC(=O)c2ccc(C(=O)NCCSCCCO[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CNC(=O)c4ccc(-c5ccccc5)cc4)O3)cc2)(C(=O)[O-])C[C@@H]1O.[Na+].[Na+]
Standard InChI: InChI=1S/C53H71N5O20S2.2Na/c1-30(60)57-41-37(62)26-52(50(71)72,77-45(41)43(66)39(64)28-56-49(70)36-12-10-33(11-13-36)32-8-4-3-5-9-32)75-20-6-22-79-24-18-54-47(68)34-14-16-35(17-15-34)48(69)55-19-25-80-23-7-21-76-53(51(73)74)27-38(63)42(58-31(2)61)46(78-53)44(67)40(65)29-59;;/h3-5,8-17,37-46,59,62-67H,6-7,18-29H2,1-2H3,(H,54,68)(H,55,69)(H,56,70)(H,57,60)(H,58,61)(H,71,72)(H,73,74);;/q;2*+1/p-2/t37-,38-,39+,40+,41+,42+,43+,44+,45+,46+,52+,53+;;/m0../s1
Standard InChI Key: AJAYZVKIUHTXOJ-BZUHYQSSSA-L
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1162.30 | Molecular Weight (Monoisotopic): 1161.4134 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Prescher H, Schweizer A, Frank M, Kuhfeldt E, Ring J, Nitschke L.. (2022) Targeting Human CD22/Siglec-2 with Dimeric Sialosides as Novel Oligosaccharide Mimetics., 65 (15.0): [PMID:35881556] [10.1021/acs.jmedchem.2c00765] |
Source(1):